Cargando…

Gastric cancer: Epidemiology, risk factors and prevention strategies

Gastric cancer (GC) is a global health problem, with more than 1 million people newly diagnosed with GC worldwide each year. GC is more prevalent in less developed countries than in more developed countries. About half of all GC cases worldwide occur in East Asia, notably China. Globally, overall in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Lei, Ying, Xiangji, Liu, Shuo, Lyu, Guoqing, Xu, Zekuan, Zhang, Xi, Li, Huichao, Li, Qingyu, Wang, Ning, Ji, Jiafu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797232/ https://www.ncbi.nlm.nih.gov/pubmed/33446993 http://dx.doi.org/10.21147/j.issn.1000-9604.2020.06.03

Ejemplares similares

Evaluation of Different Breast Cancer Screening Strategies for High-Risk Women in Beijing, China: A Real-World Population-Based Study
por: Zhang, Xi, et al.
Publicado: (2021)

Performance of different colorectal cancer screening strategies: a long-term passive follow-up population-based screening program in Beijing, China
por: Zhang, Xi, et al.
Publicado: (2023)

Epidemiological Characteristics of Peripheral T-Cell Lymphoma: A Population-Based Study
por: Liu, Shuo, et al.
Publicado: (2022)

Effects of insurance status on long-term survival among non-small cell lung cancer (NSCLC) patients in Beijing, China: A population-based study
por: Wang, Zheng, et al.
Publicado: (2020)

Laparoscopic versus open gastrectomy for elderly local advanced gastric cancer patients: study protocol of a phase II randomized controlled trial
por: Li, Ziyu, et al.
Publicado: (2018)

Associations of centralization with health care quality for gastric cancer patients receiving gastrectomy in China
por: Ji, Jiafu, et al.
Publicado: (2021)

Development and validation of a novel staging system integrating the number and location of lymph nodes for gastric adenocarcinoma
por: Li, Ziyu, et al.
Publicado: (2020)

The clinical value and usage of inflammatory and nutritional markers in survival prediction for gastric cancer patients with neoadjuvant chemotherapy and D2 lymphadenectomy
por: Li, Ziyu, et al.
Publicado: (2020)

Development and validation of an artificial neural network prognostic model after gastrectomy for gastric carcinoma: An international multicenter cohort study
por: Li, Ziyu, et al.
Publicado: (2020)

Correlative Analysis Between Adverse Events of Preoperative Chemotherapy and Postoperative Complications of Gastric Cancer
por: Wu, Zhouqiao, et al.
Publicado: (2021)

Optimal Timing to Surgery After Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer
por: Wang, Yinkui, et al.
Publicado: (2020)

Secular trends in incidence of lung cancer by histological type in Beijing, China, 2000−2016
por: Yang, Lei, et al.
Publicado: (2019)

Oxaliplatin plus S-1 or capecitabine as neoadjuvant or adjuvant chemotherapy for locally advanced gastric cancer with D2 lymphadenectomy: 5-year follow-up results of a phase II−III randomized trial
por: Xue, Kan, et al.
Publicado: (2018)

An Innovative Prognostic Model Based on Four Genes in Asian Patient with Gastric Cancer
por: Chen, Jiahui, et al.
Publicado: (2021)

5-Fu-Based Doublet Regimen in Patients Receiving Perioperative or Postoperative Chemotherapy for Locally Advanced Gastric Cancer: When to Start and How Long Should the Regimen Last?
por: Liu, Zining, et al.
Publicado: (2021)

Clinical predictive efficacy of C-reactive protein for diagnosing infectious complications after gastric surgery
por: Shi, Jinyao, et al.
Publicado: (2020)

Different prognostic implication of ypTNM stage and pTNM stage for gastric cancer: a propensity score-matched analysis
por: Li, Ziyu, et al.
Publicado: (2019)

Efficacy of chemotherapy versus surgery as initial treatment for gastric cancer with positive peritoneal cytology
por: Li, Bailong, et al.
Publicado: (2023)

Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
por: Liu, Zining, et al.
Publicado: (2021)

Risk factors associated with peritoneal carcinomatosis of gastric cancer in staging laparoscopy: A systematic review and meta-analysis
por: Guan, Guangmin, et al.
Publicado: (2022)

Combination of tumor markers predicts progression and pathological response in patients with locally advanced gastric cancer after neoadjuvant chemotherapy treatment
por: Liu, Zining, et al.
Publicado: (2021)

Duration of Perioperative Chemotherapy in Locally Advanced Gastric Cancer: A “Less Is More” Question When ypN0 Is Achieved
por: Liu, Zining, et al.
Publicado: (2021)

Epidemiology of gastric cancer: global trends, risk factors and prevention
por: Rawla, Prashanth, et al.
Publicado: (2018)

Early diagnosis of anastomotic leakage after colorectal cancer surgery using an inflammatory factors-based score system
por: Shi, Jinyao, et al.
Publicado: (2022)

Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies
por: Machlowska, Julita, et al.
Publicado: (2020)

Updates on global epidemiology, risk and prognostic factors of gastric cancer
por: Yang, Wen-Juan, et al.
Publicado: (2023)

In-Hospital Mortality Risk Model of Gastric Cancer Surgery: Analysis of a Nationwide Institutional-Level Database With 94,277 Chinese Patients
por: Wu, Zhouqiao, et al.
Publicado: (2019)

Laparoscopic or open distal gastrectomy after neoadjuvant chemotherapy for advanced gastric cancer: study protocol for a randomised phase II trial
por: Li, Ziyu, et al.
Publicado: (2018)

Global burden prediction of gastric cancer during demographic transition from 2020 to 2040
por: Yan, Chao, et al.
Publicado: (2023)

Predicting peritoneal carcinomatosis of gastric cancer: A simple model to exempt low-risk patients from unnecessary staging laparoscopy
por: Li, Zhemin, et al.
Publicado: (2022)

Epidemiology of gastric cancer and risk factors
por: Ottavia, Cavatorta, et al.
Publicado: (2018)

TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer
por: Cheng, Xiaojing, et al.
Publicado: (2020)

Correction: TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer
por: Cheng, Xiaojing, et al.
Publicado: (2022)

Gastric cancer: epidemiology, prevention, classification, and treatment
por: Sitarz, Robert, et al.
Publicado: (2018)

A decision analysis comparing three strategies for peritoneal lavage cytology testing in staging of gastric cancer in China
por: He, Qifei, et al.
Publicado: (2020)

Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies
por: Fung, Brian M, et al.
Publicado: (2019)

Analysis of risk factors and prevention strategies for functional delayed gastric emptying in 1243 patients with distal gastric cancer
por: Pang, Tao, et al.
Publicado: (2020)

Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway
por: Fu, Runjia, et al.
Publicado: (2019)

Updates on Malaria Epidemiology and Prevention Strategies
por: González-Sanz, Marta, et al.
Publicado: (2023)

Characteristics of cancer susceptibility genes mutations in 282 patients with gastric adenocarcinoma
por: Ji, Ke, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g53t7iapduguo0gnvfuoodeo22